It is a pharma private limited company based in New Delhi, Delhi, India, established in 1995.
1995 | New Delhi, Delhi, India | ActiveSakshi Pharmaceuticals Private Limited, a active private limited company, was established on 26 April 1995 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74899DL1995PTC067859. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹2.52 Cr.
It upholds a compliant status. Its leadership includes Sakshi Jain (Director), Ish Kumar Chadha (Director). Past directors included Tanya Jain, Sakshi Jain, Ish Kumar Chadha. It holds ₹4.50 Cr open charges and ₹10.37 Cr settled loans. Its latest AGM occurred on 28 September 2024, with the balance sheet filed on 31 March 2024. It is based at S-22 Green Park Extension, New Delhi, Delhi, 110016.
U74899DL1995PTC067859
067859
26 April 1995
₹3.00 Cr
₹2.52 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Sakshi Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sakshi Jain | Director | 15 Nov 2019 | Current |
| Ish Kumar Chadha | Director | 02 Apr 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 10 Apr 2021 | Past |
| Pramod Abcsdd | Additional Director | 15 Oct 2020 | Past |
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
| Pramod Abcsdd | Director | 21 Nov 2019 | Past |
| Pramod Abcsdd | Director | 21 Nov 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sakshi Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 4197.47% increase. The company also saw a substantial improvement in profitability, with a 602.67% increase in profit. The company's net worth Soared by an impressive increase of 11.79%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Sakshi Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹45,000,000.00
₹103,700,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Nov 2021 | Others | ₹4.50 Cr | Open |
| 09 Sep 2021 | Hdfc Bank Limited | ₹10.00 Cr | Satisfied |
| 26 Mar 2013 | Corporation Bank | ₹3.70 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Sakshi Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sakshi Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sakshi Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Others of Rs. 4.50 Cr registered on 13 Nov 2021 with Charge ID 100513927 was modified on 31 Oct 2025. was documented.
The activity Sakshi Pharmaceuticals Private Limited last Annual general meeting of members was held on 28 Sep 2024 as per latest MCA records. was completed.
Progress on Sakshi Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
Progress on A charge registered on 09 Sep 2021 via Charge ID 100486428 with Hdfc Bank Limited was fully satisfied on 11 Apr 2022. was documented.
The activity A charge registered on 26 Mar 2013 via Charge ID 10424839 with Corporation Bank was fully satisfied on 14 Mar 2022. was completed.
The activity A charge with Others amounted to Rs. 4.50 Cr with Charge ID 100513927 was registered on 13 Nov 2021. was completed.
The CIN of Sakshi Pharmaceuticals Private Limited is U74899DL1995PTC067859.
Sakshi Pharmaceuticals Private Limited is headquartered at S-22 Green Park Extension, New Delhi, Delhi, 110016.
Sakshi Pharmaceuticals Private Limited was incorporated on 26 April 1995.
The current directors of Sakshi Pharmaceuticals Private Limited are
The primary industry of Sakshi Pharmaceuticals Private Limited is Trade.
Sakshi Pharmaceuticals Private Limited is unlisted.
The authorized capital of Sakshi Pharmaceuticals Private Limited is ₹3.00 Cr, and the paid-up capital is ₹2.52 Cr.
The compliance status of Sakshi Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX